Prof. Dr. Anne Krug from the Institute for Immunology, Biomedical Center, LMU Munich, will give a guest lecture at IVI on the topic “Dendritic Cells and Type I Interferon Shape Yellow Fever Vaccine Efficacy.”

The lecture will take place on Thursday, November 12, 2026 at 3:00 pm (s.t.) in the Pharmacology Lecture Hall, Peter-Mayr-Straße 1, 6020 Innsbruck.

We are delighted to welcome her as our guest and cordially invite all interested parties to attend the lecture and the subsequent discussion.

This event is accredited with 2 DFP points in the subject “Clinical Microbiology and Virology.” In-person attendance is required.

Short Bio

Anne Krug is an immunologist and physician-scientist who studies the role of dendritic cells in antiviral immune defense and vaccine responses. She began her career as a physician in internal medicine at the LMU University Hospital in Munich (1999–2000) and went on to postdoctoral research at the Department of Pathology and Immunology at Washington University in St. Louis, USA (2001–2003). From 2004 to 2014 she led a research group and worked as a physician at the Department of Internal Medicine II, Klinikum rechts der Isar, TU Munich. Since 2014 she has been Full Professor at the Institute for Immunology, Biomedical Center, LMU Munich.

Her group investigates how dendritic cell subpopulations develop, how plastic they are, and how they specialize in function. They also study how these cells sense viral nucleic acids and how they shape T cell and antibody responses to infection and vaccination. Her work has uncovered subset-specific mechanisms of virus sensing and, more recently, an alternative pathway by which conventional dendritic cells can arise from precursors with lymphoid features. A particular focus is yellow fever vaccination as a model of a highly effective human vaccine response. In a 2025 study in PNAS, her team showed that interferon-driven activation of dendritic cells and monocytes in the first week after vaccination correlates with early antibody responses. She is also co-speaker of the dendritic cell study group of the German Society for Immunology (DGfI).